BAKER HEART AND DIABETES INSTITUTE
- Country
- π¦πΊAustralia
- Ownership
- -
- Established
- 1858-01-01
- Employees
- 481
- Market Cap
- -
- Website
- http://www.bakeru.edu
Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease
- Conditions
- Interventions
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 3
- Registration Number
- NCT02021019
- Locations
- π¦πΊ
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
Renal Denervation for Uncontrolled Hypertension
- First Posted Date
- 2013-12-20
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Registration Number
- NCT02016573
Renal Denervation for Resistant Hypertension
- First Posted Date
- 2013-05-30
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 5
- Registration Number
- NCT01865240
- Locations
- π¦πΊ
Baker IDI Heart & Diabetes Inst, Melbourne, Victoria, Australia
Renal Denervation for Complicated Hypertension
- First Posted Date
- 2013-05-30
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 23
- Registration Number
- NCT01865253
- Locations
- π¦πΊ
Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
- Conditions
- Interventions
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2016-02-09
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 2
- Registration Number
- NCT01799057
- Locations
- π¦πΊ
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
- Conditions
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 80
- Registration Number
- NCT01568307
- Locations
- π¦πΊ
Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
π¦πΊBallarat Health Service Psychiatric Services, Ballarat, Victoria, Australia
π¦πΊAlfred and Baker Medical Unit - Alfred Hospital, Melbourne, Victoria, Australia
Alleviating the Metabolic Side Effects of Antipsychotic Medications
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Registration Number
- NCT01567124
- Locations
- π¦πΊ
Ballarat Health Service Psychiatric Services, Ballarat, Victoria, Australia
π¦πΊAlfred and Baker Medical Unit - Alfred Hospital, Melbourne, Victoria, Australia
π¦πΊBaker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
Polycystic Ovary Syndrome - Improving Outcomes
- First Posted Date
- 2012-01-05
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 42
- Registration Number
- NCT01504321
- Locations
- π¦πΊ
Heart Centre, Alfred Hospital, Prahran, Victoria, Australia
Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01483053
- Locations
- π¦πΊ
Monash Medical Centre - Monash Health, Clayton, Victoria, Australia
π¦πΊAlfred and Baker Medical Unit - Alfred Hospital, Melbourne, Victoria, Australia
π¦πΊBaker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Target Recruit Count
- 100
- Registration Number
- NCT01360710
- Locations
- π¦πΊ
BakerIDI Heart and Diabetes Institute, Prahran, Victoria, Australia